Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib

Journal of the American Academy of Dermatology

Volumn 67, Issue 6, 2012, Pages

  Gerami, Pedram ^a   Sorrell, Jennifer ^a   Martini, Mary ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VEMURAFENIB;

ABDOMEN; ADULT; BRAF GENE; CASE REPORT; CENTRAL NERVOUS SYSTEM METASTASIS; DISEASE SEVERITY; DYSPLASIA; DYSPLASTIC NEVUS; EPILUMINESCENCE MICROSCOPY; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; LUNG METASTASIS; LYMPH NODE; MALE; MELANOMA; METASTASIS; NECK DISSECTION; ONCOGENE; PRIORITY JOURNAL; SCALP; SKIN BIOPSY; TREATMENT RESPONSE;

EID: 84867928898     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.05.031     Document Type: Article

References (5)

1. P.B. Chapman, A. Hauschild, C. Robert, J.B. Haaren, P. Ascierto, and J. Larkin Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507 2516
2. A. Vultur, J. Villanueva, and M. Herlyn BRAF inhibitor unveils its potential against advanced melanoma Cancer Cell 18 2010 301 302
3. S. Dalle, N. Poulalhon, and L. Thomas Vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 365 2011 1448 1449 author reply 1450
4. P.I. Poulikakos, C. Zhang, G. Bollag, K.M. Shokat, and N. Rosen RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature 464 2010 427 430
5. G. Hatzivassiliou, K. Song, I. Yen, B.J. Brandhuber, D.J. Anderson, and R. Alvarado RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth Nature 464 2010 431 435